| |
| |
|
| Insider
Information: |
Palekar Rohan |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
778,643 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,183,048 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
778,643 |
|
|
| Total
Value |
$4,183,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -16.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Chief Commercial Officer |
2011-04-20 |
16,666 |
2008-01-14 |
0 |
Premium* |
|
|
Avanir Pharmaceuticals |
AVNR |
SVP & Chief Commercial... |
2014-11-28 |
302,806 |
2012-04-03 |
0 |
Premium* |
|
|
89bio, Inc. |
ETNB |
|
2024-04-01 |
459,171 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDVN |
Medivation Inc |
Chief Commercial OfficerOffice |
• – – |
2008-01-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2010-05-17 |
4 |
S |
$10.91 |
$27,270 |
D/D |
(2,500) |
7,500 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2010-02-01 |
4 |
AS |
$33.59 |
$587,825 |
D/D |
(17,500) |
10,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-12-07 |
4 |
AS |
$33.27 |
$399,240 |
D/D |
(12,000) |
15,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2011-03-21 |
4 |
AS |
$16.05 |
$120,375 |
D/D |
(7,500) |
16,666 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2011-04-20 |
4 |
AS |
$22.63 |
$282,825 |
D/D |
(12,500) |
16,666 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-09-10 |
4 |
AS |
$25.78 |
$143,746 |
D/D |
(5,576) |
17,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-06-30 |
4 |
AS |
$22.21 |
$266,567 |
D/D |
(12,000) |
19,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-09-09 |
4 |
AS |
$26.00 |
$166,994 |
D/D |
(6,424) |
19,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-03-18 |
4 |
AS |
$16.30 |
$163,000 |
D/D |
(10,000) |
21,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-09-10 |
4 |
OE |
$15.71 |
$56,179 |
D/D |
3,576 |
22,576 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2010-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,666 |
24,166 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-09-09 |
4 |
OE |
$15.71 |
$100,921 |
D/D |
6,424 |
25,424 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-12-07 |
4 |
OE |
$15.71 |
$157,100 |
D/D |
10,000 |
27,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2010-02-01 |
4 |
OE |
$15.71 |
$196,375 |
D/D |
12,500 |
27,500 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2011-04-20 |
4 |
OE |
$15.71 |
$196,375 |
D/D |
12,500 |
29,166 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2008-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ETNB |
89bio, Inc. |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| MDVN |
Medivation Inc |
Chief Commercial Officer |
• – – |
2009-06-30 |
4 |
OE |
$15.71 |
$157,100 |
D/D |
10,000 |
31,000 |
0 |
- |
|
| ETNB |
89bio, Inc. |
Chief Executive Officer |
• • – |
2021-07-07 |
4 |
B |
$17.07 |
$85,350 |
D/D |
5,000 |
35,000 |
2.81 |
% |
|
| ETNB |
89bio, Inc. |
Chief Executive Officer |
• • – |
2021-07-08 |
4 |
B |
$16.25 |
$32,500 |
D/D |
2,000 |
37,000 |
2.81 |
% |
|
| ETNB |
89bio, Inc. |
Chief Executive Officer |
• • – |
2022-01-27 |
4 |
B |
$7.50 |
$37,500 |
D/D |
5,000 |
43,345 |
2.81 |
% |
|
| ETNB |
89bio, Inc. |
Chief Executive Officer |
• • – |
2022-01-28 |
4 |
B |
$6.14 |
$15,350 |
D/D |
2,500 |
45,845 |
2.81 |
% |
|
| AVNR |
Avanir Pharmaceuticals |
SVP & Chief Commercial Officer |
• – – |
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
SVP & Chief Commercial Officer |
• – – |
2012-12-13 |
4 |
B |
$2.46 |
$24,598 |
D/D |
10,000 |
60,000 |
2.74 |
- |
|
57 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
